S-1 · resale registration
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Wholesale-Drugs, Proprietaries & Druggists' SundriesIndustry: Medical - PharmaceuticalsCountry: GRExchange: Nasdaq
DilutionScan read 23 of Cosmos Health Inc.'s SEC filings and found 9 warrant series, 9 convertibles, 1 ATM program, 6 shelf registrations, 5 S-1 registrations and 6 completed offerings on file for COSM. The latest dilution event on file is an offering on Jun 30, 2026. Analysis updated Sep 28, 2026.
COSM
Going-concern warning, negative cash runway
Cosmos Health is a tiny pharmaceutical firm growing revenue fast but burning cash even faster. FY 2025 revenue hit $65.3M (up 20% YoY), yet the company posted a $19.1M net loss and burned $8.5M in free cash flow.
Raise routes on file: effective shelf + pending S-1 + effective S-1 · latest dilution event 126 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jun 30, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2024
Proposed maximum
Shares registered
Issued 2025
Proposed maximum
Shares registered
Issued 2022
Proposed maximum
Shares registered
Issued 2022
Proposed maximum
Shares registered
Issued 2022
Proposed maximum
Shares registered
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2022
Total capacity
Sold to date
Issued 2022
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2025
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2025
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Medical - Pharmaceuticals, then the closest in size. All tickers A to Z